Table 5 Factors influencing the seroprevalence of anti-MSP1_₄₂ antibodies

Age group (year)

 <1

60 (41.1%)

1

1

 1–4

373 (37.3%)

0.85 (0.59–61.21)

1.05 (0.73–1.51)

0.8

 5–10

342 (47.57%)

1.3 (0.96–1.86)

1.28 (0.87–1.87)

0.19

Gender

 Female

385 (41.98%)

1

1

 Male

390 (41.14%)

0.96 (0.8–1.16)

0.98 (0.82–1.18)

0.87

Nutritional status

 Stunting

286 (43.27%)

1.15 (0.92–1.45)

0.97 (0.75–1.24)

0.8

 Underweight

205 (41.25)

0.93 (0.71–1.2)

0.93 (0.82–1.43)

0.59

 Retard staturo-pondéral

75 (38.27%)

0.89 (0.64–1.24)

0.93 (0.67–1.29)

0.68

Anemia

 No

213 (41.36%)

1

1

 Yes

562 (41.63%)

1.02 (0.82–1.24)

0.99 (0.78–1.23)

0.86

Malaria parasite

 No

726 (40.97%)

1

1

 Yes

49 (52.69%)

1.6 (1.05–2.43)

1.01 (0.65–1.55)

0.95

Residence area

 Keur Soce

315 (31.53%)

1

1

 Velingara

460 (53.12%)

2.46 (2.04–2.97)

2.4 (1.95–2.95)

<10⁻³